Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Anamarija M. Perry, MD, Diebold Jacques, MD, Bharat N. Nathwani, MD, Kenneth Angus Maclennan, MD, H Konrad Müller-Hermelink, Eugene Boilesen, Martin Bast, BS, James O. Armitage, MD, Dennis D. Weisenburger, MD

Blood (2015) 126 (23): 1484.

https://doi.org/10.1182/blood.V126.23.1484.1484

Published: 2015

Journal Articles

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Javier A. Laurini, Anamarija M. Perry, Eugene Boilesen, Jacques Diebold, Kenneth A. MacLennan, H. Konrad Müller-Hermelink, Bharat N. Nathwani, James O. Armitage, Dennis D. Weisenburger

Blood (2012) 120 (24): 4795–4801.

https://doi.org/10.1182/blood-2012-07-440073

Published: 2012

Journal Articles

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

Blood (2011) 118 (1): 148–155.

https://doi.org/10.1182/blood-2011-02-335216

Published: 2011

Includes: Supplemental data

Journal Articles

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

Blood (2010) 116 (23): 4916–4925.

https://doi.org/10.1182/blood-2010-03-276766

Published: 2010

Journal Articles

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36

Tiemo Katzenberger, Jörg Kalla, Ellen Leich, Heike Stöcklein, Elena Hartmann, Sandra Barnickel, Swen Wessendorf, M. Michaela Ott, Hans Konrad Müller-Hermelink, Andreas Rosenwald, German Ott

Blood (2009) 113 (5): 1053–1061.

https://doi.org/10.1182/blood-2008-07-168682

Published: 2009

Journal Articles

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Blood (2008) 112 (11): 475.

https://doi.org/10.1182/blood.V112.11.475.475

Published: 2008

Journal Articles

Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma

Angela Zöllinger, Thorsten Stühmer, Manik Chatterjee, Stefan Gattenlöhner, Eugenia Haralambieva, Hans-Konrad Müller-Hermelink, Mindaugas Andrulis, Axel Greiner, Carmen Wesemeier, Jörg C. Rath, Hermann Einsele, Ralf C. Bargou

Blood (2008) 112 (8): 3403–3411.

https://doi.org/10.1182/blood-2007-11-119362

Published: 2008

Includes: Supplemental data

Journal Articles

Mutations in the DNA-binding codons of TP53 , which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Ken H. Young, Dennis D. Weisenburger, Bhavana J. Dave, Lynette Smith, Warren Sanger, Javeed Iqbal, Elias Campo, Jan Delabie, Randy D. Gascoyne, German Ott, Lisa Rimsza, H. Konrad Müller-Hermelink, Elaine S. Jaffe, Andreas Rosenwald, Louis M. Staudt, Wing C. Chan, Timothy C. Greiner

Blood (2007) 110 (13): 4396–4405.

https://doi.org/10.1182/blood-2007-02-072082

Published: 2007

Includes: Supplemental data

Journal Articles

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Georg Lenz, MD, George Wright, PhD, Sandeep Dave, MD, Alexander Kohlmann, PhD, Wenming Xiao, PhD, John Powell, MS, Hong Zhao, Weihong Xu, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Lorraine May, MD, Dennis D. Weisenburger, MD, Tim Greiner, MD, Julie Vose, MD, James O. Armitage, MD, Javeed Iqbal, MD, Martin Bast, MD, Kai Fu, MD, Elias Campo, MD, Emili Montserrat, MD, Armando Lopez-Guillermo, MD, Pedro Jares, MD, Antonio Martinez, MD, Betty Gibbs, MD, Lisa M. Rimsza, MD, Richard I. Fisher, MD, Rita M. Braziel, MD, Ray Tubbs, MD, James Cook, MD, Brad Pohlman, MD, John Sweetenham, MD, Gunhild Troen, MD, Erlend B. Smeland, MD, Jan Delabie, MD, Stein Kvaloy, MD, Harald Holte, MD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, Nicole Grant, MD, Elena Hartmann, MD, Andreas Rosenwald, MD, German Ott, MD, Hans-Konrad Muller-Hermelink, MD, T. Andrew Lister, MD, Mickey Williams, PhD, Lothar Wieczorek, PhD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD

Blood (2007) 110 (11): 348.

https://doi.org/10.1182/blood.V110.11.348.348

Published: 2007

Journal Articles

Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.

Georg Lenz, MD, George W. Wright, PhD, Sandeep Dave, MD, Wenming Xiao, PhD, John Powell, MS, Andreas Rosenwald, MD, Hans-Konrad Muller-Hermelink, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Jan Delabie, MD, Erlend B. Smeland, MD, Lisa Rimsza, MD, Richard I. Fisher, MD, Wing C. Chan, MD, Louis M. Staudt, MD

Blood (2007) 110 (11): 2631.

https://doi.org/10.1182/blood.V110.11.2631.2631

Published: 2007

Journal Articles

SNP Array Analysis Reveals Copy Number Alterations and Uniparental Disomy in Mantle Cell Lymphomas at High Resolution.

Elena M. Hartmann, MD, Itziar Salaverria, Silvia Bea, PhD, Andreas Zettl, MD, Pedro Jares, PhD, Francesc Bosch, MD, PhD, German Ott, MD, Hans Konrad Muller-Hermelink, MD, Andreas Rosenwald, MD, Elias Campo, MD

Blood (2007) 110 (11): 1585.

https://doi.org/10.1182/blood.V110.11.1585.1585

Published: 2007

Journal Articles

CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma.

Blood (2007) 110 (11): 692.

https://doi.org/10.1182/blood.V110.11.692.692

Published: 2007

Journal Articles

Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression

Stefan Gattenloehner, Sergei Chuvpilo, Claudia Langebrake, Dirk Reinhardt, Hans-Konrad Müller-Hermelink, Edgar Serfling, Angela Vincent, Alexander Marx

Blood (2007) 110 (6): 2027–2033.

https://doi.org/10.1182/blood-2007-02-074203

Published: 2007

Includes: Supplemental data

Journal Articles

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Blood (2007) 109 (11): 4599–4606.

https://doi.org/10.1182/blood-2006-08-039859

Published: 2007

Journal Articles

Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma.

Georg Lenz, MD, Inga Nagel, PhD, Reiner Siebert, MD, Warren Sanger, MD, George W. Wright, PhD, Hong Zhao, Andreas Rosenwald, MD, Hans-Konrad Muller-Hermelink, MD, Randy D. Gascoyne, MD, Elias Campo, MD, Elaine S. Jaffe, MD, Erlend B. Smeland, MD, Richard I. Fisher, MD, W. Michael Kuehl, MD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD

Blood (2006) 108 (11): 356.

https://doi.org/10.1182/blood.V108.11.356.356

Published: 2006

Journal Articles

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Robin A. Roberts, George Wright, Andreas R. Rosenwald, Marina A. Jaramillo, Thomas M. Grogan, Thomas P. Miller, Yvette Frutiger, Wing C. Chan, Randy D. Gascoyne, German Ott, H. Konrad Muller-Hermelink, Louis M. Staudt, Lisa M. Rimsza

Blood (2006) 108 (1): 311–318.

https://doi.org/10.1182/blood-2005-11-4742

Published: 2006

Journal Articles

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Blood (2006) 107 (3): 1101–1107.

https://doi.org/10.1182/blood-2005-04-1510

Published: 2006

Journal Articles

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Blood (2005) 106 (9): 3183–3190.

https://doi.org/10.1182/blood-2005-04-1399

Published: 2005

Includes: Supplemental data

Journal Articles

High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA.

Blood (2004) 104 (11): 697.

https://doi.org/10.1182/blood.V104.11.697.697

Published: 2004

Journal Articles

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Lisa M. Rimsza, Robin A. Roberts, Thomas P. Miller, Joseph M. Unger, Michael LeBlanc, Rita M. Braziel, Dennis D. Weisenberger, Wing C. Chan, H. Konrad Muller-Hermelink, Elaine S. Jaffe, Randy D. Gascoyne, Elias Campo, Deborah A. Fuchs, Catherine M. Spier, Richard I. Fisher, Jan Delabie, Andreas Rosenwald, Louis M. Staudt, Thomas M. Grogan

Blood (2004) 103 (11): 4251–4258.

https://doi.org/10.1182/blood-2003-07-2365

Published: 2004

NARROW

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma

Mutations in the DNA-binding codons of TP53 , which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.

SNP Array Analysis Reveals Copy Number Alterations and Uniparental Disomy in Mantle Cell Lymphomas at High Resolution.

CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma.

Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression

Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival

Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma.

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA.

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only